Presented by John W. Colberg, MD, Yale University School of Medicine,New Haven, CT.
NCCN awards funding to 4 advanced prostate cancer research projects
The research projects are assessing combination therapies in advanced prostate cancer that include the use of relugolix.
How APPs can bridge the gap in urologist shortages
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
FDA accepts IND application for VMB-100 for stress urinary incontinence
The phase 2a open-label dose ascending study to assess the safety, tolerability, and efficacy of VMB-100 in female patients with moderate SUI is expected to begin in the first half of 2024.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Can remote patient monitoring help combat the staffing shortage?
"As more patients become interested in remote patient monitoring and case studies continue to show improved patient outcomes, practices must seek ways to integrate these tools into their workflows," writes Lucienne Marie Ide, MD, PhD.
Dr. Mian on emerging molecular biomarkers for genitourinary cancers
On an episode of Cleveland Clinic’s Cancer Advances podcast, host Dale Shepard, MD, PhD, talks with Omar Mian, MD, PhD, about emerging molecular biomarkers for genitourinary cancers.
2 Clarke Drive Cranbury, NJ 08512